The major structural components of high density lipoproteins were determined in the sera of 638 male employees aged 40 years and older. It was demonstrated that the HDL apolipoprotein A-I/HDL cholesteröl ratio äs well äs the HDL apolipoprotein A-II/HDL eholesterol ratio are similarly correlated to a cumulative score of established risk factors for atherosclerosis. Most important, however, is the finding that the correlation of these ratios to the risk factor rating of atherosclerosis is found in subgroups with normal or elevated HDL cholesteröl values. Furthermore, it is shown that the relative content of apolipoproteinsand A-II in individual HDL is partly dependent on the plasma concentration of HDL cholesteröl and triglycerides.
Introduction
In recent epidemiological (1) (2) (3) (4) and clinical studies (5 -6) the analysis of high density lipoprotein cholesterol (HDL cholesterol) has been shown to be a risk indicator for coronary heart disease. In contrast to HDL cholesterol, the possible relationship of HDL apolipoproteins to the risk of coronary heart disease has not yet been thoroughly investigated. Several clinical studies have demonstrated low levels of apolipoprotein A-I in subjects with coronary heart disease (7 -9), while apolipoprotein A-II in patients with coronary heart disease has been found to be low (10, 11) or unchanged (6, 8) . In contrast to these clinical studies there is a lack of the prospective epidemiological data needed to demonstrate the predictive potency of HDL apolipoproteins with respect to coronary heart disease. Recently, from initial results of our epidemiological study in Company employees in Westphalia, it was demonstrated that HDL apolipoprotein A-I correlates with several risk factors for coronary heart disease but fails to correlate with the risk factors triacylglycerol and relative body weight (12) . To date, no comparable studies on HDL apolipoprotein A-II are available. For a greater insight into the relationship between HDL apolipoproteins and the risk factors for coronary heart disease, we measured both HDL apolipoproteins A-I and A-II in 638 male Company employees in addition to HDL cholesterol. Since the incidence of coronary heart disease in women and in men under 40 years of age is very low, our study was limited to individuals aged 40 years and above.
Materials and Methods

Sample material
Sera were obtained from male employees aged 40 years and over. All of these were participants in the "Prospective epidemiological study of Company employees in Westphalia" (13) . Data given here are cross sectional. The proband's mean age was 49 ± 6 years, the maximum age being 64 years; observed body weight expressed s Broca index ranged from 69% to 151% with a mean value of 106.6% ± 12.2%.
Analysis of HDL components
HDL components were analysed in the supernatant after precipitation of apolipoprotein B-containing lipoproteins with phosphotungstic acid/MgC! 2 using the Boehringer Mannheim Test Combination (test no. 1442434) (14) . HDL cholesterol was analysed enzymatically using the CHOD-PAP method (Boehringer Mannheim, test combination nol 237574) (14) . HDL phosphatidyl choline was determined with an enzyinatic colour test using the centrifugal analyser Cobas Bio (Hoffmann La R che) s described preViously (15) .
Apolipoprotein A-I was determined turbidimetrically using the Cobas Bio analyser.
The incubation mixture contained: -300 μΐ phosphate-buffered polyethyleneglycol solution (Immunochemical System Beckman) -20 μΐ d uted sample (dilution l: 160 with 9 g/l NaCl) -20 μΐ antibody solution (Behring antibody no. 103315 B was diluted with l : 2.5 with 9 g/l NaCl) -10μ1Η 2 Ο As a blank, 300 μΐ phosphate-buffered polyethyleneglycol solution was used, containing 20 μΐ diluted sample (dilution l: 160 with 9 g/l NaCl) and 10 Using this turbidimetric method identical results were obtained when compared with data observed using kinetic nephelometry (16) .
HDL apolipoprotein A-II was measured by turbidimetry using the Cobas Bio analyser s described in detail elsewhere (17) .
LDL cholesterol LDL cholesterol was calculated using the Friedewald method (18).
Total cholesterol, triacylglycerol, uric acid Serum levels of cholesterol, triacylglycerol, glucose and uric acid were determined with the SMAC II Analyser (Techiucon GmbH, Bad V bel, FRG) s described elsewhere (13) .
Statistics
For statistical calculations we used the statistical package for the social sciences (SPSS). To describe felationships to risk factors Spearman's correlation coefflcients were chosen since the risk factors were not always normally distributed, s proved by the Kolmogorov-Smirnow test. The correlations pf apolipoproteins to the coronary risk score were calculated by KendalTs τ because of the high number of tied ranks. Differences in the distribution between subgroups were tested by the Kruskal-' Wallis test. The level of significance was set at 0.05. HDL apolipoprotein A-II/HDL cholesterol ratio and risk factors, a cumulative risk factor rating was established for each subject. It was based on relative weight, diastolic blood pressure, cigarette smoking, cholesterol value and exercise. A score of 0, l or 2 was allocated for each of these measurements (tab. 1) and the sum of these individual scores was taken s the cumulative rating (19) . The relation between each of the three parameters and increasing risk score was significant (p < 0.001 each). The distribution of the three parameters in the subgroups with a cumulative risk rating score of 0, l, 2-6 are demonstrated in figures 3, 4 and 5 where additionally the median values are indicated. The differences in the distributions between the subgroups are significant (Kruskal-Wallis test, p < 0.001 each). The relationship between the HDL apolipoprotein A-I/HDL cholesterol ratio and the cumulative risk rating score was comparable to the relationship of HDL cholesterol and the risk\score (tab. 2). ratio was negatively correlated with triacylglycerol (r: -0.124, p < 0.001) (flg. 7, tab. 3). In individuals with triacylglycerol < 1.71 mmol/1, the HDL apolipoprotein A-I/HDL apolipoprotein A-II ratio was found to be higher (3.51 ± 0.48) than in individuals with triacylglycerol ranging from 1.71 to 2.27 mmol/1 (3.33 ± 0.43) or hypertriacylglycerolaemic individuals > 2.27 mmol/1 (3.33 ± 0.49). On the other band, there were no differences in the HDL apolipoprotein A-I/HDL apolipoprotein A-II ratio between hypertriacylglycerolaemic individuals and individuals with medium triacylglycerol values.
Discussion
In our present study we report only data on men 40 years and older, since this group obviously has a higher coronary risk than women or men under 40. With respect to HDL cholesteibl and HDL apolipoprotein A-I, the data obtained from men 40 years and older did not differ significantly from data reported previously for Company employees from 25 to 64 years old (12) . In addition to our previous study, HDL apolipoprotein A-II values were also measüred.
As previously reported (19) (20) and that an inverse correlation exists between HDL and VLDL in plasma (21) . Furthermore, it has been shown that a less dense HDL2 subfraction (relative high lipid/apolipoprotein ratio) is epidemiologically associated with reduced coronary heart disease, while a more dense HDL 3 subfraction (relatively low lipid/ apolipoprotein ratio) is thought to be unrelated to such disease (22, 23) . Nevertheless, recent studies have shown that HDL in individuals with hypertriacylglycerolaemia mainly consist of HDL 3 , which are enriched with apolipoproteins and triglycerides and which are depleted of cholesterol (24) . Furthermore, it has been reported that alcohol consumption, which is known to be associated with high HDL cholesterol (25 -27) and frequently with hypertriacylglycerolaemia (28, 29), mainly resulted in an enhanced level of HDL 3 mass without affecting HDL 2 mass (30) . It has been shown that the apolipoprotein A-I/apolipoprotein A-II ratio in HDL/2 is higher than that in HDL 3 (31, 32) . Therefore, in individuals with heigh HDL cholesterol levels (which are associated with lower triacylglycerol) and a similarly high apolipoprotein A-I/apolipoprotein A-II ratio, a higher HDL2/HDL 3 ratio may exist in comparison to individuals with lower HDL cholesterol levels (which are associated with higher triacylglycerol) and a similarly low apolipoprotein A-I/apolipoprotein A-II ratio. However, it is of interest to note that the HDL lipoprotein composition in our study did not differ between individuals with moderate hyperlipoproteinaemia and individuals with obviously enhanced lipid levels. Possibly, in hypertriacylglycerolaemics, the HDL apolipoprotein A-I/apolipoprotein A-II ratio may additionally be a reflection of the change in apolipoprotein composition in HDL particles in different density classes. 5 .00
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